These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22368385)

  • 1. Metabolic pathway analysis and molecular docking analysis for identification of putative drug targets in Toxoplasma gondii: novel approach.
    Gautam B; Singh G; Wadhwa G; Farmer R; Singh S; Singh AK; Jain PA; Yadav PK
    Bioinformation; 2012; 8(3):134-41. PubMed ID: 22368385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective host autophagy is induced during the intracellular parasite
    White MD; Angara RK; Dias LT; Shinde DD; Thomas VC; Augusto L
    mSphere; 2024 Jul; ():e0036924. PubMed ID: 38980070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of myristoylation in
    Broncel M; Dominicus C; Vigetti L; Nofal SD; Bartlett EJ; Touquet B; Hunt A; Wallbank BA; Federico S; Matthews S; Young JC; Tate EW; Tardieux I; Treeck M
    Elife; 2020 Jul; 9():. PubMed ID: 32618271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Host autophagy is exploited by the intracellular parasite
    White MD; Angara RK; Dias LT; Shinde DD; Thomas VC; Augusto L
    bioRxiv; 2023 Dec; ():. PubMed ID: 38106117
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting Heat Shock Proteins 60 and 70 of Toxoplasma gondii as a Potential Drug Target: In Silico Approach.
    Ashwinder K; Kho MT; Chee PM; Lim WZ; Yap IK; Choi SB; Yam WK
    Interdiscip Sci; 2016 Dec; 8(4):374-387. PubMed ID: 26297309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A
    Piro F; Masci S; Kannan G; Focaia R; Schultz TL; Thaprawat P; Carruthers VB; Di Cristina M
    mSphere; 2024 Jan; 9(1):e0059723. PubMed ID: 38051073
    [No Abstract]   [Full Text] [Related]  

  • 7. Dual transcriptional profiling of mice and Toxoplasma gondii during acute and chronic infection.
    Pittman KJ; Aliota MT; Knoll LJ
    BMC Genomics; 2014 Sep; 15(1):806. PubMed ID: 25240600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of potential apicoplast associated therapeutic targets in human and animal pathogen Toxoplasma gondii ME49.
    Saremy S; Boroujeni ME; Bhattacharjee B; Mittal V; Chatterjee J
    Bioinformation; 2011; 7(8):379-83. PubMed ID: 22347778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic pathway analysis approach: identification of novel therapeutic target against methicillin resistant Staphylococcus aureus.
    Uddin R; Saeed K; Khan W; Azam SS; Wadood A
    Gene; 2015 Feb; 556(2):213-26. PubMed ID: 25436466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Computational screening of FDA-approved drugs to identify potential TgDHFR, TgPRS, and TgCDPK1 proteins inhibitors against Toxoplasma gondii.
    Gharibi Z; Shahbazi B; Gouklani H; Nassira H; Rezaei Z; Ahmadi K
    Sci Rep; 2023 Apr; 13(1):5396. PubMed ID: 37012275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Plasmodium Atg3-Atg8 Interaction Inhibitors Identifies Novel Alternative Mechanisms of Action in Toxoplasma gondii.
    Varberg JM; LaFavers KA; Arrizabalaga G; Sullivan WJ
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29158278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Computational characterisation of
    Aygün C; Mutlu Ö
    J Biomol Struct Dyn; 2022 Mar; 40(5):1952-1969. PubMed ID: 33063633
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.
    Jensen KD; Camejo A; Melo MB; Cordeiro C; Julien L; Grotenbreg GM; Frickel EM; Ploegh HL; Young L; Saeij JP
    mBio; 2015 Feb; 6(2):e02280. PubMed ID: 25714710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transcriptomic analysis of mouse liver reveals a potential hepato-enteric pathogenic mechanism in acute Toxoplasma gondii infection.
    He JJ; Ma J; Elsheikha HM; Song HQ; Huang SY; Zhu XQ
    Parasit Vectors; 2016 Aug; 9(1):427. PubMed ID: 27488578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dichloroacetate and Pyruvate Metabolism: Pyruvate Dehydrogenase Kinases as Targets Worth Investigating for Effective Therapy of Toxoplasmosis.
    Ferrarini MG; Nisimura LM; Girard RMBM; Alencar MB; Fragoso MSI; Araújo-Silva CA; Veiga AA; Abud APR; Nardelli SC; Vommaro RC; Silber AM; France-Sagot M; Ávila AR
    mSphere; 2021 Jan; 6(1):. PubMed ID: 33408226
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential drug targets in Mycobacterium tuberculosis through metabolic pathway analysis.
    Anishetty S; Pulimi M; Pennathur G
    Comput Biol Chem; 2005 Oct; 29(5):368-78. PubMed ID: 16213791
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phytoecdysteroids as modulators of the Toxoplasma gondii growth rate in human and mouse cells.
    Dzitko K; Grzybowski MM; Pawełczyk J; Dziadek B; Gatkowska J; Stączek P; Długońska H
    Parasit Vectors; 2015 Aug; 8():422. PubMed ID: 26272689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protein targets of thiazolidinone derivatives in Toxoplasma gondii and insights into their binding to ROP18.
    Molina D; Cossio-Pérez R; Rocha-Roa C; Pedraza L; Cortes E; Hernández A; Gómez-Marín JE
    BMC Genomics; 2018 Nov; 19(1):856. PubMed ID: 30497375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptomic profiling of long non-coding RNAs and messenger RNAs in the liver of mice during Toxoplasma gondii infection.
    Zou Y; Yang X; Chen C; Ma H; Cao HW; Jiang J; Wei XY; Zhang XX
    Parasit Vectors; 2024 Jan; 17(1):20. PubMed ID: 38229193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pathogenicity and virulence of
    Sanchez SG; Besteiro S
    Virulence; 2021 Dec; 12(1):3095-3114. PubMed ID: 34895084
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.